Health Care

Alembic Pharmaceuticals Limited (NSE:APLLTD) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Raj Kumar Baheti -- Director, Finance & Chief…

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Dinesh Sodani -- GM Finance Chintan…

Ajanta Pharma Limited (NSE:AJANTPHARM) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Yogesh Agrawal -- Managing Director Rajesh Agrawal -- Joint Managing…

VIMTA LABS LTD (NSE:VIMTALABS) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Vishal Manchanda -- Vice President, Institutional Research Narahari…

Jyothy Laboratories Limited (NSE:JYOTHYLAB) Q4 FY23 Earnings Concall dated May. 03, 2023. Corporate Participants: Sanjay Agarwal -- Chief Financial Officer M R…

Rossari Biotech Ltd (NSE:ROSSARI) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Aesha Shah -- Investor Relations Edward Menezes -- Executive Chairman…

Meghmani Organics Limited (NSE:MOL) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Ankit Patel -- Chief Executive Officer Gurjant Singh…

RPG LIFE SCIENCES LTD (NSE:RPGL) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Yugal Sikri -- Managing Director Analysts: Sudarshan…

Aarti Drugs Limited (NSE:AARTIDRUGS) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Adhish Patil -- Chief Financial Officer Harshit M.…

Glenmark Life Sciences Limited (NSE:GLS) Q4 FY23 Earnings Concall dated Apr. 28, 2023. Corporate Participants: Soumi Rao -- General Manager, Corporate Communications…

https://youtu.be/5Vtl-XMN8qg Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding…

Laurus Labs Limited (NSE:LAURUSLABS) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Satyanarayana Chava -- Founder & Chief Executive Officer…

Dhampur Bio Organics Ltd (NSE:DBOL) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Mr. Navin Agrawal -- Head of Institutional…

Syngene International Ltd (NSE:SYNGENE) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Avantika Mishra -- Investor Relations Jonathan Hunt -- Managing Director…

To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active…

Syngene reported Total revenue for Q4 FY23 of ₹994 Crore, up from ₹759 Crore year on year, a growth of…

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Q4 FY23 Earnings Concall dated Apr. 24, 2023. Corporate Participants: Unidentified Speaker -- Devinder Khurana -- Chief Financial…

Panacea Biotec Limited is an Indian pharmaceutical company that is engaged in research, development, and manufacturing of pharmaceuticals, vaccines, and…

“I am happy to report that our hospital business continued to deliver consistent performance in all key operational and financial…

“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses.…